Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

Initially developed for atopic dermatitis, Enveda's lead asset ENV-294 is now showing promise in treating asthma.

• Topical treatments: Over-the-counter 1% hydrocortisone cream can help with mild flare-ups. For more severe cases, pediatricians may prescribe stronger topical steroids or calcineurin inhibitors.

Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting ... across multiple indications, including atopic dermatitis (AD), in which it is considered the gold standard.

The Food and Drug Administration (FDA) has approved the biologic drug dupilumab (Dupixent). Doctors prescribe it for people with moderate to severe atopic dermatitis when topical treatments do not ...

Discover a study that used social media platforms to explore topical steroid withdrawal among individuals with atopic ...

The use of Sanofi’s Dupixent in atopic dermatitis has set a high benchmark for competitors ... Among other topics, Hudson discussed the success of Dupixent (dupilumab), highlighting that it has ...